Correlation Between Aldeyra and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aldeyra and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aldeyra and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aldeyra and Checkpoint Therapeutics, you can compare the effects of market volatilities on Aldeyra and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aldeyra with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aldeyra and Checkpoint Therapeutics.
Diversification Opportunities for Aldeyra and Checkpoint Therapeutics
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Aldeyra and Checkpoint is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Aldeyra and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Aldeyra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aldeyra are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Aldeyra i.e., Aldeyra and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Aldeyra and Checkpoint Therapeutics
Given the investment horizon of 90 days Aldeyra is expected to under-perform the Checkpoint Therapeutics. In addition to that, Aldeyra is 1.06 times more volatile than Checkpoint Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest 367.00 in Checkpoint Therapeutics on August 26, 2024 and sell it today you would earn a total of 8.00 from holding Checkpoint Therapeutics or generate 2.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aldeyra vs. Checkpoint Therapeutics
Performance |
| Timeline |
| Aldeyra |
| Checkpoint Therapeutics |
Aldeyra and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aldeyra and Checkpoint Therapeutics
The main advantage of trading using opposite Aldeyra and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aldeyra position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.| Aldeyra vs. Tarsus Pharmaceuticals | Aldeyra vs. Travere Therapeutics | Aldeyra vs. Eton Pharmaceuticals | Aldeyra vs. Viridian Therapeutics |
| Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |